Background: Description of antibiotic susceptibility of isolates from dogs and cats with hepatobiliary disease is limited.
Objectives: To describe antibiotic susceptibility patterns of bacteria associated with hepatobiliary disease in dogs and cats over a 10 year-period.
Animals: Three hundred nine dogs and cats.
Methods: Bacterial species and antibiotic susceptibility data from positive bile and liver tissue cultures were reviewed from both a Veterinary Teaching Hospital and a private laboratory. Prevalence of multidrug-resistant (MDR) bacteria was assessed, along with its association with previous antibiotic administration.
Results: A total of 343 bacterial isolates were included from 310 cultures. Monobacterial cultures were more frequent (91%, 283/310). Gram-negative bacteria were predominant (67%, 227/340), with Escherichia coli (49%, 136/340), Staphylococcus spp. (14%, 47/340), and Enterococcus spp. (10%, 34/340) being the most prevalent isolates. Resistance of gram-negative bacteria were: amoxicillin-clavulanic acid (33%, 70/214), aminopenicillins (47%, 96/205), and fluoroquinolones (16%, 67/417); for gram-positive bacteria: amoxicillin-clavulanic acid (12%, 5/41), aminopenicillins (16%, 11/67), and fluoroquinolones (17%, 35/111). Resistance was significantly higher for aminopenicillins, first-generation cephalosporins, TMPS, tetracyclines, and fluoroquinolones during 2010-2014 compared to 2015-2019. MDR isolates comprised 40% (135/430) of all isolates, 30% (41/136) of E. coli, and 68% (23/34) of Enterococcus spp. A significantly higher incidence of MDR bacteria was observed in animals with previous antibiotic treatment (81%, 17/21) compared to those without (30%, 22/75; p < 0.001).
Conclusion And Clinical Importance: Conducting culture and sensitivity testing remains crucial in dogs and cats suspected of hepatobiliary infection to ensure effective treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876079 | PMC |
http://dx.doi.org/10.1111/jvim.70007 | DOI Listing |
Sci Adv
March 2025
Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai 200065, China.
Liver fibrosis is an inevitable stage in the progression of most chronic liver diseases. Early diagnosis and treatment of liver fibrosis are crucial for effectively managing chronic liver conditions. However, there lacks a noninvasive and sensitive imaging method capable of early assessing fibrosis activity.
View Article and Find Full Text PDFSci Adv
March 2025
Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.
Pancreatic cancer (PC) is a highly metastatic malignancy. More than 80% of patients with PC present with advanced-stage disease, preventing potentially curative surgery. The neuropeptide Y (NPY) system, best known for its role in controlling energy homeostasis, has also been shown to promote tumorigenesis in a range of cancer types, but its role in PC has yet to be explored.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
March 2025
Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Chronic infections with hepatitis E virus (HEV), especially those of genotype 3 (G3), frequently lead to liver fibrosis and cirrhosis in patients. However, the causation and mechanism of liver fibrosis triggered by chronic HEV infection remain poorly understood. Here, we found that the viral multiple-domain replicase (ORF1) undergoes unique ubiquitin-proteasomal processing leading to formation of the EV-erived MAD ctivator (HDSA), a viral polypeptide lacking putative helicase and RNA polymerase domains.
View Article and Find Full Text PDFPLoS Negl Trop Dis
March 2025
Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, United States of America.
Trypanosoma cruzi is a single-celled eukaryotic parasite responsible for Chagas disease, a major cause of morbidity and mortality in Central and South America. While the host-pathogen interactions of T. cruzi have been extensively studied in vertebrate models, investigations into its interactions within its insect host remain limited.
View Article and Find Full Text PDFPLoS One
March 2025
Centre for Proteomic Research, Biological Sciences and Institute for Life Sciences, Building 85, University of Southampton, Southampton, United Kingdom.
Oesophageal adenocarcinoma (OAC) is the 7th most common cancer in the United Kingdom (UK) and remains a significant health challenge. This study presents a proteomic analysis of seven OAC donors complementing our previous neoantigen identification study of their human leukocyte antigen (HLA) immunopeptidomes. Our small UK cohort were selected from donors undergoing treatment for OAC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!